Virtual reality-based Avatar Therapy for treatment-resistant major depressive disorder: A pilot study

Area of Science:

• Psychiatry and Mental Health
• Virtual Reality Applications
• Clinical Psychology

Background:

• Major Depressive Disorder (MDD) affects many individuals, with a significant portion unresponsive to conventional treatments, leading to Treatment-Resistant Depression (TRD).
• TRD presents a major clinical and public health challenge, necessitating novel therapeutic approaches.
• Avatar Therapy, a novel virtual reality intervention, has been developed to address TRD by incorporating experiential and relational elements.

Purpose of the Study:

• To evaluate the short-term efficacy of Avatar Therapy for individuals diagnosed with Treatment-Resistant Depression (TRD).
• To assess the impact of Avatar Therapy on depressive symptom severity, anxiety, self-esteem, quality of life, and overall functioning.

Main Methods:

• A pilot clinical trial involving 12 participants with TRD.
• Participants engaged in real-time virtual reality dialogues with an avatar representing a key figure influencing their depressive symptoms, animated by a therapist.
• Primary outcomes included response and remission rates and depressive symptom severity; secondary outcomes assessed anxiety, self-esteem, quality of life, and functioning, analyzed using linear mixed-effects models.

Main Results:

• Among completers, an 80% response rate and a 20% remission rate were observed.
• Significant large reductions in depressive symptoms were noted via both self-report (d=1.48) and clinician ratings (d=1.36).
• Substantial improvements were also recorded in anxiety severity (d=1.27), self-esteem (d=1.11), quality of life (d=1.42), and functioning (d=1.21).

Conclusions:

• Avatar Therapy demonstrates promising preliminary efficacy for treating individuals with Treatment-Resistant Depression (TRD).
• Further research is warranted, including larger controlled trials to confirm these findings and assess long-term outcomes.